Shunsuke Teraoka
Wakayama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
How to report and discuss subgroup analyses in clinical practice guidelines? Evaluation procedure of the clinical and statistical relevancy.
Journal: International journal of clinical oncology
Published: February 10, 2025
Final Analysis Data and Exploratory Biomarker Analysis of a Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib Monotherapy for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: The WJOG9717L Study.
Journal: JTO clinical and research reports
Published: May 13, 2024
Mannitol versus furosemide in patients with thoracic malignancies who received cisplatin-based chemotherapy using short hydration: A randomized phase II trial.
Journal: Cancer medicine
Published: November 06, 2023
Long-Term Efficacy and Safety of Lorlatinib in Japanese Patients With ALK-Positive Advanced NSCLC-A Brief Report From the CROWN Study.
Journal: JTO clinical and research reports
Published: September 28, 2023
Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Phase 2 Nonrandomized Controlled Trial.
Journal: JAMA oncology
Published: September 07, 2023
Association of immune-related adverse events with durvalumab efficacy after chemoradiotherapy in patients with unresectable Stage III non-small cell lung cancer.
Journal: British journal of cancer
Published: September 03, 2023
A Phase II Study of High-Flow Nasal Cannula for Relieving Dyspnea in Advanced Cancer Patients.
Journal: Journal of pain and symptom management
Published: August 10, 2023
Adjacent angle size correlates with diagnostic sensitivity of endobronchial ultrasonography with a guide sheath.
Journal: Journal of thoracic disease
Published: May 08, 2023
Tumor Microenvironment Landscape of NSCLC Reveals Resistance Mechanisms for Programmed Death-Ligand 1 Blockade After Chemoradiotherapy: A Multicenter Prospective Biomarker Study (WJOG11518L:SUBMARINE).
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: March 23, 2023
Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC.
Journal: JTO clinical and research reports
Published: January 17, 2023
First-Line Lorlatinib Versus Crizotinib in ALK-Positive NSCLC: Japanese Subgroup Analysis of CROWN.
Journal: JTO clinical and research reports
Published: November 04, 2022
Last Updated: 09/26/2026